| Name | Title | Contact Details |
|---|
At Matrix, we understand that access to care often translates to quality of care. In 2007, we broke the mold on the traditional physician office visit care model, and decided that the best place for care is in the home. That`s why we pioneered the use of Nurse Practitioners to visit health plan members where they needed care the most—in their home or a nursing facility. It is this pioneering attitude that has helped us continue to innovate the way care is delivered. With advanced technology, innovative solutions, highly skilled Nurse Practitioners and exceptional processes, Matrix excels at delivering the right care, at the right place, by the right person…every time. We are changing the way healthcare is delivered.
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.
IntraMed Educational Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Consult-Pro is a East York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FLAVORx, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bethesda, MD. To find more information about FLAVORx, Inc., please visit www.flavorx.com